In a subset of patients the hormone leptin can be leveraged as a therapeutic agent to move fat out of the liver.

A phase 3 clinical trial finds an anti-inflammatory drug used in rheumatoid arthritis can preserve lung function in patients with systemic sclerosis.

Inhibiting IRE1α, a molecule activated by the endoplasmic reticulum in neutrophils, counters disease progression in lupus mice.

The new approach blocks the interaction between cancer cells and immune receptors, showing promise in mice.

Research finds juvenile myositis and lupus share an inflammatory pathway, but their  pathophysiological differences may serve as diagnostic biomarkers in future studies.

A meta-analysis finds that vision impairment and blindness are tied to an increased risk of mortality, prompting the need to address global eye health disparities.